Breaking News Instant updates and real-time market news.

FTHM

Fathom

$5.07 /

-0.13 (-2.50%)

05:55
09/28/22
09/28
05:55
09/28/22
05:55

Fathom management to meet with Roth Capital

Meetings to be held in Milwaukee on September 27 and in Chicago on September 28 hosted by Roth Capital.

  • 28

    Sep

  • 31

    Oct

  • 18

    Nov

OTHER BREAKING NEWS FROM THE FLY

Earnings
Oxford Industries reports Q3 adjusted EPS $1.46, consensus $1.22 » 16:10
12/07/22
12/07
16:10
12/07/22
16:10
OXM

Oxford Industries

$109.11 /

+0.28 (+0.26%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OXM Oxford Industries
$109.11 /

+0.28 (+0.26%)

OXM Oxford Industries
$109.11 /

+0.28 (+0.26%)

09/21/22 Citi
Oxford Industries upgraded to Neutral from Sell at Citi
09/20/22 CL King
Oxford Industries' acquisition of Johnny Was viewed positively, says CL King
09/20/22 Piper Sandler
Oxford Industries price target raised to $135 from $130 at Piper Sandler
08/23/22 Piper Sandler
Oxford Industries price target raised to $130 from $110 at Piper Sandler
OXM Oxford Industries
$109.11 /

+0.28 (+0.26%)

OXM Oxford Industries
$109.11 /

+0.28 (+0.26%)

Downgrade
Wolverine World Wide downgraded to Hold from Buy at Williams Trading » 16:10
12/07/22
12/07
16:10
12/07/22
16:10
WWW

Wolverine World Wide

$10.19 /

-0.13 (-1.26%)

Williams Trading analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WWW Wolverine World Wide
$10.19 /

-0.13 (-1.26%)

WWW Wolverine World Wide
$10.19 /

-0.13 (-1.26%)

11/14/22 UBS
Wolverine World Wide price target lowered to $15 from $20 at UBS
11/09/22 CL King
Wolverine World Wide downgraded to Buy from Strong Buy at CL King
11/09/22 Williams Trading
Wolverine World Wide downgraded to Hold from Buy at Williams Trading
10/20/22 Williams Trading
Wolverine World Wide upgraded to Buy from Hold at Williams Trading
WWW Wolverine World Wide
$10.19 /

-0.13 (-1.26%)

WWW Wolverine World Wide
$10.19 /

-0.13 (-1.26%)

WWW Wolverine World Wide
$10.19 /

-0.13 (-1.26%)

Earnings
BuzzFeed sees Q4 revenue $129M-$134M, consensus $131.3M » 16:09
12/07/22
12/07
16:09
12/07/22
16:09
BZFD

BuzzFeed

$1.05 /

-0.03 (-2.78%)

CEO Jonah Peretti says:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BZFD BuzzFeed
$1.05 /

-0.03 (-2.78%)

BZFD BuzzFeed
$1.05 /

-0.03 (-2.78%)

11/21/22 Cowen
BuzzFeed downgraded to Market Perform from Outperform at Cowen
08/11/22 BofA
BuzzFeed downgraded to Underperform from Neutral at BofA
05/17/22 Cowen
BuzzFeed price target lowered to $5 from $6 at Cowen
02/04/22 BofA
BuzzFeed initiated with a Neutral at BofA
BZFD BuzzFeed
$1.05 /

-0.03 (-2.78%)

BZFD BuzzFeed
$1.05 /

-0.03 (-2.78%)

BZFD BuzzFeed
$1.05 /

-0.03 (-2.78%)

Hot Stocks
IMV Inc. shareholders approve reverse stock split at 88% » 16:08
12/07/22
12/07
16:08
12/07/22
16:08
IMV

IMV Inc.

/

+

IMV Inc. announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IMV IMV Inc.
/

+

IMV IMV Inc.
/

+

Syndicate
Prometheus announces $250M common stock offering » 16:08
12/07/22
12/07
16:08
12/07/22
16:08
RXDX

Prometheus

$96.97 /

+60.99 (+169.51%)

Prometheus Biosciences…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RXDX Prometheus
$96.97 /

+60.99 (+169.51%)

RXDX Prometheus
$96.97 /

+60.99 (+169.51%)

16:08 Today RBC Capital
Prometheus price target raised to $111 from $66 at RBC Capital
12:01 Today Guggenheim
Prometheus price target raised to $185 from $75 at Guggenheim
11:27 Today Piper Sandler
Prometheus price target raised to $114 from $67 at Piper Sandler
11:01 Today Stifel
Stifel 'thoroughly impressed' with Prometheus' data in UC and CD
RXDX Prometheus
$96.97 /

+60.99 (+169.51%)

RXDX Prometheus
$96.97 /

+60.99 (+169.51%)

RXDX Prometheus
$96.97 /

+60.99 (+169.51%)

Earnings
Verint sees FY23 EPS $2.50, consensus $2.48 » 16:08
12/07/22
12/07
16:08
12/07/22
16:08
VRNT

Verint

$37.53 /

+0.06 (+0.16%)

Sees FY23 revenue $900M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VRNT Verint
$37.53 /

+0.06 (+0.16%)

VRNT Verint
$37.53 /

+0.06 (+0.16%)

09/08/22 Wedbush
Verint price target lowered to $56 from $65 at Wedbush
09/08/22 RBC Capital
Verint price target lowered to $58 from $61 at RBC Capital
04/12/22 Goldman Sachs
Verint downgraded to Neutral from Buy at Goldman Sachs
03/30/22 RBC Capital
Verint price target raised to $61 from $57 at RBC Capital
VRNT Verint
$37.53 /

+0.06 (+0.16%)

VRNT Verint
$37.53 /

+0.06 (+0.16%)

Recommendations
Prometheus price target raised to $111 from $66 at RBC Capital » 16:08
12/07/22
12/07
16:08
12/07/22
16:08
RXDX

Prometheus

$96.97 /

+60.99 (+169.51%)

RBC Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RXDX Prometheus
$96.97 /

+60.99 (+169.51%)

RXDX Prometheus
$96.97 /

+60.99 (+169.51%)

12:01 Today Guggenheim
Prometheus price target raised to $185 from $75 at Guggenheim
11:27 Today Piper Sandler
Prometheus price target raised to $114 from $67 at Piper Sandler
11:01 Today Stifel
Stifel 'thoroughly impressed' with Prometheus' data in UC and CD
07:41 Today Wells Fargo
Prometheus shares should be up 'meaningfully' after UC/CD data, says Wells Fargo
RXDX Prometheus
$96.97 /

+60.99 (+169.51%)

RXDX Prometheus
$96.97 /

+60.99 (+169.51%)

RXDX Prometheus
$96.97 /

+60.99 (+169.51%)

Downgrade
RBC downgrades Mercer to Sector Perform on near-term headwinds » 16:07
12/07/22
12/07
16:07
12/07/22
16:07
MERC

Mercer

$13.58 /

+0.065 (+0.48%)

RBC Capital analyst Paul…

RBC Capital analyst Paul Quinn downgraded Mercer International to Sector Perform from Outperform with a price target of $14, down from $17. The analyst continues to like the longer-term story, but sees near-term headwinds for the business that dampen his enthusiasm for the shares over a one-year horizon. He expects pulp prices to continue to ease and says input costs "are also a challenge." Mercer management stated that it expects fiber costs in its German pulp business to continue to rise sequentially into Q4, Quinn tells investors in a research note.

ShowHide Related Items >><<
MERC Mercer
$13.58 /

+0.065 (+0.48%)

MERC Mercer
$13.58 /

+0.065 (+0.48%)

16:03 Today RBC Capital
Mercer downgraded to Sector Perform from Outperform at RBC Capital
07/06/22 Credit Suisse
Mercer upgraded to Outperform from Neutral at Credit Suisse
07/06/22 Credit Suisse
Mercer upgraded to Outperform from Neutral at Credit Suisse
06/23/22 TD Securities
Mercer price target lowered to $15 from $17 at TD Securities
MERC Mercer
$13.58 /

+0.065 (+0.48%)

MERC Mercer
$13.58 /

+0.065 (+0.48%)

Earnings
Rent The Runway raises FY22 revenue view to $293M-$295M from $285M-$290M » 16:07
12/07/22
12/07
16:07
12/07/22
16:07
RENT

Rent The Runway

$1.32 /

-0.04 (-2.94%)

Consensus $287.55M. Sees…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RENT Rent The Runway
$1.32 /

-0.04 (-2.94%)

RENT Rent The Runway
$1.32 /

-0.04 (-2.94%)

11/18/22 Morgan Stanley
Rent The Runway downgraded to Equal Weight from Overweight at Morgan Stanley
09/13/22 Morgan Stanley
Rent The Runway price target lowered to $13 from $14 at Morgan Stanley
09/13/22 JMP Securities
Rent The Runway price target lowered to $6 from $12 at JMP Securities
09/13/22 Barclays
Rent The Runway price target lowered to $6 from $7 at Barclays
RENT Rent The Runway
$1.32 /

-0.04 (-2.94%)

RENT Rent The Runway
$1.32 /

-0.04 (-2.94%)

RENT Rent The Runway
$1.32 /

-0.04 (-2.94%)

Hot Stocks
Verint announces $250M share buyback  16:07
12/07/22
12/07
16:07
12/07/22
16:07
VRNT

Verint

$37.50 /

+0.03 (+0.08%)

 
ShowHide Related Items >><<
VRNT Verint
$37.50 /

+0.03 (+0.08%)

VRNT Verint
$37.50 /

+0.03 (+0.08%)

09/08/22 Wedbush
Verint price target lowered to $56 from $65 at Wedbush
09/08/22 RBC Capital
Verint price target lowered to $58 from $61 at RBC Capital
04/12/22 Goldman Sachs
Verint downgraded to Neutral from Buy at Goldman Sachs
03/30/22 RBC Capital
Verint price target raised to $61 from $57 at RBC Capital
VRNT Verint
$37.50 /

+0.03 (+0.08%)

VRNT Verint
$37.50 /

+0.03 (+0.08%)

Earnings
Kinder Morgan sees FY23 EPS $1.12, consensus $1.11 » 16:07
12/07/22
12/07
16:07
12/07/22
16:07
KMI

Kinder Morgan

$18.01 /

-0.1 (-0.55%)

Sees FY23 adjusted EBITDA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KMI Kinder Morgan
$18.01 /

-0.1 (-0.55%)

KMI Kinder Morgan
$18.01 /

-0.1 (-0.55%)

10/19/22 Barclays
Kinder Morgan price target lowered to $20 from $21 at Barclays
09/07/22 Goldman Sachs
Kinder Morgan upgraded to Neutral from Sell at Goldman Sachs
08/16/22 Barclays
Kinder Morgan price target raised to $21 from $20 at Barclays
07/20/22 Barclays
Kinder Morgan price target lowered to $20 from $21 at Barclays
KMI Kinder Morgan
$18.01 /

-0.1 (-0.55%)

KMI Kinder Morgan
$18.01 /

-0.1 (-0.55%)

KMI Kinder Morgan
$18.01 /

-0.1 (-0.55%)

KMI Kinder Morgan
$18.01 /

-0.1 (-0.55%)

Syndicate
Cutera announces $100M convertible senior notes offering » 16:07
12/07/22
12/07
16:07
12/07/22
16:07
CUTR

Cutera

$49.90 /

-0.4 (-0.80%)

Cutera announced that it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CUTR Cutera
$49.90 /

-0.4 (-0.80%)

CUTR Cutera
$49.90 /

-0.4 (-0.80%)

11/22/22 Piper Sandler
Piper would take advantage of any softness in Cutera after competitor approval
10/13/22 Stephens
Cutera resumed with an Overweight at Stephens
10/12/22 Piper Sandler
CMS proposal a positive for Med Tech sector, says Piper Sandler
09/30/22 Piper Sandler
Piper calls Cutera a 'small cap name that investors should own'
CUTR Cutera
$49.90 /

-0.4 (-0.80%)

CUTR Cutera
$49.90 /

-0.4 (-0.80%)

Earnings
Verint reports Q3 EPS 69c, consensus 59c » 16:07
12/07/22
12/07
16:07
12/07/22
16:07
VRNT

Verint

$37.50 /

+0.03 (+0.08%)

Reports Q3 revenue $226M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VRNT Verint
$37.50 /

+0.03 (+0.08%)

VRNT Verint
$37.50 /

+0.03 (+0.08%)

09/08/22 Wedbush
Verint price target lowered to $56 from $65 at Wedbush
09/08/22 RBC Capital
Verint price target lowered to $58 from $61 at RBC Capital
04/12/22 Goldman Sachs
Verint downgraded to Neutral from Buy at Goldman Sachs
03/30/22 RBC Capital
Verint price target raised to $61 from $57 at RBC Capital
VRNT Verint
$37.50 /

+0.03 (+0.08%)

VRNT Verint
$37.50 /

+0.03 (+0.08%)

Hot Stocks
Inhibikase Therapeutics provides update on clinical hold of IkT-148009 programs » 16:07
12/07/22
12/07
16:07
12/07/22
16:07
IKT

Inhibikase Therapeutics

/

+

Inhibikase Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IKT Inhibikase Therapeutics
/

+

IKT Inhibikase Therapeutics
/

+

11/16/22 JonesTrading
Inhibikase Therapeutics downgraded to Hold from Buy at JonesTrading
Hot Stocks
ROC Energy Acquisition confirms deadline extension for initial combination » 16:06
12/07/22
12/07
16:06
12/07/22
16:06
ROC

ROC Energy Acquisition

$10.15 /

+ (+0.00%)

ROC Energy Acquisition…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
Celcuity:1st patient dosed in Phase 3 trial of Gedatolisib for breast cancer » 16:06
12/07/22
12/07
16:06
12/07/22
16:06
CELC

Celcuity

$7.58 /

-0.57 (-6.99%)

Celcuity announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CELC Celcuity
$7.58 /

-0.57 (-6.99%)

CELC Celcuity
$7.58 /

-0.57 (-6.99%)

05/17/22 Craig-Hallum
Celcuity price target lowered to $20 from $30 at Craig-Hallum
Syndicate
Chefs' Warehouse announces $250M convertible senior notes offering » 16:06
12/07/22
12/07
16:06
12/07/22
16:06
CHEF

Chefs' Warehouse

$37.28 /

-0.565 (-1.49%)

The Chefs' Warehouse…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CHEF Chefs' Warehouse
$37.28 /

-0.565 (-1.49%)

CHEF Chefs' Warehouse
$37.28 /

-0.565 (-1.49%)

11/14/22 Benchmark
Chefs' Warehouse price target raised to $51 from $49 at Benchmark
09/14/22 CL King
Chefs' Warehouse currently best-positioned foodservice distributor, says CL King
08/22/22 BTIG
Chefs' Warehouse price target raised to $48 from $46 at BTIG
07/07/22 BMO Capital
Chefs' Warehouse price target raised to $48 from $44 at BMO Capital
CHEF Chefs' Warehouse
$37.28 /

-0.565 (-1.49%)

CHEF Chefs' Warehouse
$37.28 /

-0.565 (-1.49%)

Earnings
GameStop reports Q3 EPS (31c), consensus (28c) » 16:06
12/07/22
12/07
16:06
12/07/22
16:06
GME

GameStop

$22.24 /

-1.17 (-5.00%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GME GameStop
$22.24 /

-1.17 (-5.00%)

GME GameStop
$22.24 /

-1.17 (-5.00%)

10/13/22 Jefferies
GameStop transferred with a Hold at Jefferies
08/16/22 B. Riley
B. Riley downgrades 'meme stock' Bed Bath & Beyond to Sell
07/22/22 Wedbush
GameStop price target lowered to $7.50 from $30 at Wedbush
05/26/22 Wedbush
Wedbush keeps Underperform on GameStop citing valuation and cash burn concerns
GME GameStop
$22.24 /

-1.17 (-5.00%)

GME GameStop
$22.24 /

-1.17 (-5.00%)

GME GameStop
$22.24 /

-1.17 (-5.00%)

GME GameStop
$22.24 /

-1.17 (-5.00%)

Earnings
Rent The Runway sees Q4 revenue $72M-$74M, consensus $71.66M » 16:05
12/07/22
12/07
16:05
12/07/22
16:05
RENT

Rent The Runway

$1.32 /

-0.04 (-2.94%)

Sees Q4 adjusted EBITDA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RENT Rent The Runway
$1.32 /

-0.04 (-2.94%)

RENT Rent The Runway
$1.32 /

-0.04 (-2.94%)

11/18/22 Morgan Stanley
Rent The Runway downgraded to Equal Weight from Overweight at Morgan Stanley
09/13/22 Morgan Stanley
Rent The Runway price target lowered to $13 from $14 at Morgan Stanley
09/13/22 JMP Securities
Rent The Runway price target lowered to $6 from $12 at JMP Securities
09/13/22 Barclays
Rent The Runway price target lowered to $6 from $7 at Barclays
RENT Rent The Runway
$1.32 /

-0.04 (-2.94%)

RENT Rent The Runway
$1.32 /

-0.04 (-2.94%)

RENT Rent The Runway
$1.32 /

-0.04 (-2.94%)

Earnings
Rent The Runway reports Q3 EPS (56c), consensus (56c) » 16:04
12/07/22
12/07
16:04
12/07/22
16:04
RENT

Rent The Runway

$1.32 /

-0.04 (-2.94%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RENT Rent The Runway
$1.32 /

-0.04 (-2.94%)

RENT Rent The Runway
$1.32 /

-0.04 (-2.94%)

11/18/22 Morgan Stanley
Rent The Runway downgraded to Equal Weight from Overweight at Morgan Stanley
09/13/22 Morgan Stanley
Rent The Runway price target lowered to $13 from $14 at Morgan Stanley
09/13/22 JMP Securities
Rent The Runway price target lowered to $6 from $12 at JMP Securities
09/13/22 Barclays
Rent The Runway price target lowered to $6 from $7 at Barclays
RENT Rent The Runway
$1.32 /

-0.04 (-2.94%)

RENT Rent The Runway
$1.32 /

-0.04 (-2.94%)

RENT Rent The Runway
$1.32 /

-0.04 (-2.94%)

Downgrade
Mercer downgraded to Sector Perform from Outperform at RBC Capital » 16:03
12/07/22
12/07
16:03
12/07/22
16:03
MERC

Mercer

$13.58 /

+0.065 (+0.48%)

RBC Capital analyst Paul…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MERC Mercer
$13.58 /

+0.065 (+0.48%)

MERC Mercer
$13.58 /

+0.065 (+0.48%)

07/06/22 Credit Suisse
Mercer upgraded to Outperform from Neutral at Credit Suisse
07/06/22 Credit Suisse
Mercer upgraded to Outperform from Neutral at Credit Suisse
06/23/22 TD Securities
Mercer price target lowered to $15 from $17 at TD Securities
01/31/22 RBC Capital
Mercer upgraded to Outperform from Underperform at RBC Capital
MERC Mercer
$13.58 /

+0.065 (+0.48%)

MERC Mercer
$13.58 /

+0.065 (+0.48%)

Hot Stocks
Relmada Therapeutics trading halted, news pending  16:01
12/07/22
12/07
16:01
12/07/22
16:01
RLMD

Relmada Therapeutics

$4.16 /

-0.04 (-0.95%)

 
ShowHide Related Items >><<
RLMD Relmada Therapeutics
$4.16 /

-0.04 (-0.95%)

RLMD Relmada Therapeutics
$4.16 /

-0.04 (-0.95%)

11/11/22 SVB Securities
Relmada 'still has a chance' for positive depression data, says SVB
10/14/22 BofA
Axsome shares could react positively to Relmada trial failure, says BofA
10/14/22 Goldman Sachs
Relmada Therapeutics downgraded to Neutral from Buy at Goldman Sachs
10/14/22 Truist
Relmada Therapeutics downgraded to Hold from Buy at Truist
RLMD Relmada Therapeutics
$4.16 /

-0.04 (-0.95%)

  • 09
    Dec
RLMD Relmada Therapeutics
$4.16 /

-0.04 (-0.95%)

RLMD Relmada Therapeutics
$4.16 /

-0.04 (-0.95%)

Conference/Events
First Republic management to meet virtually with Stephens » 16:01
12/07/22
12/07
16:01
12/07/22
16:01
FRC

First Republic

$117.25 /

-1.28 (-1.08%)

Stephens Banks-Midwest…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FRC First Republic
$117.25 /

-1.28 (-1.08%)

FRC First Republic
$117.25 /

-1.28 (-1.08%)

12/05/22 Morgan Stanley
First Republic downgraded to Underweight from Equal Weight at Morgan Stanley
12/05/22 Morgan Stanley
Silvergate Capital downgraded to Underweight from Equal Weight at Morgan Stanley
12/01/22 Wolfe Research
First Republic price target lowered to $131 from $133 at Wolfe Research
11/10/22 Wedbush
First Republic price target lowered to $130 from $135 at Wedbush
FRC First Republic
$117.25 /

-1.28 (-1.08%)

  • 02
    Aug
FRC First Republic
$117.25 /

-1.28 (-1.08%)

FRC First Republic
$117.25 /

-1.28 (-1.08%)

Periodicals
Third Point sold Cano Health stake last week, Bloomberg reports » 16:00
12/07/22
12/07
16:00
12/07/22
16:00
CANO

Cano Health

$1.72 /

-0.04 (-2.28%)

Daniel Loeb's Third…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CANO Cano Health
$1.72 /

-0.04 (-2.28%)

CANO Cano Health
$1.72 /

-0.04 (-2.28%)

11/16/22 Citi
Cano Health price target lowered to $5 from $7 at Citi
11/10/22 Cowen
Cano Health downgraded at Cowen with liquidity 'now a plausible 2023 concern'
11/10/22 Cowen
Cano Health downgraded to Market Perform from Outperform at Cowen
11/10/22 Raymond James
Cano Health downgraded to Market Perform from Outperform at Raymond James
CANO Cano Health
$1.72 /

-0.04 (-2.28%)

CANO Cano Health
$1.72 /

-0.04 (-2.28%)

CANO Cano Health
$1.72 /

-0.04 (-2.28%)

CANO Cano Health
$1.72 /

-0.04 (-2.28%)

Hot Stocks
Prelude Therapeutics trading resumes  16:00
12/07/22
12/07
16:00
12/07/22
16:00
PRLD

Prelude Therapeutics

$5.56 /

-0.725 (-11.54%)

 
ShowHide Related Items >><<
PRLD Prelude Therapeutics
$5.56 /

-0.725 (-11.54%)

PRLD Prelude Therapeutics
$5.56 /

-0.725 (-11.54%)

11/21/22 BofA
Prelude Therapeutics downgraded to Underperform at BofA after PRMT5 discontinued
11/21/22 BofA
Prelude Therapeutics downgraded to Underperform from Neutral at BofA
11/17/22 H.C. Wainwright
Prelude Therapeutics price target lowered to $15 from $16 at H.C. Wainwright
09/09/22 Morgan Stanley
Morgan Stanley downgrades Prelude Therapeutics, sees better opportunities
PRLD Prelude Therapeutics
$5.56 /

-0.725 (-11.54%)

PRLD Prelude Therapeutics
$5.56 /

-0.725 (-11.54%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.